Sage Therapeutics, Inc. Assets, Fair Value Disclosure
Sage Therapeutics, Inc. had Assets, Fair Value Disclosure of $364.35 million as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2025-07-30
- 2025-06-30: Assets, Fair Value Disclosure $364.35M.
- 2025-03-31: Assets, Fair Value Disclosure $420.77M.
- 2024-12-31: Assets, Fair Value Disclosure $503.64M.
- 2024-09-30: Assets, Fair Value Disclosure $567.83M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2025-06-30 | $364.35M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $420.77M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $503.64M 10-Q · filed 2025-07-30 | |
| 2024-09-30 | $567.83M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $645.77M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $715.76M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $750.74M 10-K · filed 2025-02-11 | |
| 2023-09-30 | $875.09M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.00B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $1.11B 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $1.27B 10-K · filed 2024-02-14 | |
| 2022-09-30 | $1.39B 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.51B 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $1.62B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $1.74B 10-K · filed 2023-02-16 | $1.74B 10-K · filed 2022-02-24 |
| 2021-09-30 | $1.84B 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $1.91B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $2.00B 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $2.10B 10-K · filed 2022-02-24 | |
| 2020-09-30 | $668.54M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $756.52M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $872.76M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.01B 10-K · filed 2021-02-24 | |
| 2019-09-30 | $1.12B 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.24B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.35B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $922.78M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $1.02B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.09B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $1.08B 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $518.85M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $243.45M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $285.93M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $342.56M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $397.48M 10-K · filed 2018-02-22 |